Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept + NB-UVB for Psoriasis
NCT00110981Phase 4Completed
- Sponsor
- Amgen
- Start
- Mar 2005
- Primary completion
- Feb 2006
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 4 trial of etanercept in psoriasis, sponsored by Amgen. Started Mar 2005; status: completed.
02
Drugs
etanercept
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00110981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110981.